Am J Dermatopathol

1. CASILLAS AC, Muhlbauer A, Barragan VA, Jefferson I, et al
   A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
   Am J Dermatopathol. 2024;46:137-146.
   

   >> Share

   
   
2. LOHMAN ME, Kim YH, Steen AJ, Demer AM, et al
   The Promise and Pitfalls of PRAME Immunohistochemistry During Mohs Surgery: Early Findings.
   Am J Dermatopathol. 2024;46:191-192.
   

   >> Share

   
   

   
   J Am Acad Dermatol

3. MORR C, Jade Prechtel T, Hardacker R, Bell M, et al
   Impact of skin cancer screening on melanoma thickness and stage.
   J Am Acad Dermatol. 2024 Feb 13:S0190-9622(24)00348.
   

   >> Share

   
   
4. NEALE H, Plumptre I, Belazarian L, Wiss K, et al
   Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi.
   J Am Acad Dermatol. 2024;90:e107-e108.
   

   >> Share

   
   
5. GRANT-KELS JM
   JAAD Game Changer: Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
   J Am Acad Dermatol. 2024;90:674.
   

   >> Share

   
   

   
   Melanoma Res

6. TEIXEIRA RJ, de Souza VG, Sorroche BP, Paes VG, et al
   Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy.
   Melanoma Res. 2024 Feb 16. doi: 10.1097/CMR.0000000000000958.
   

   >> Share

   
   
7. ZHANG W, Wang S
   Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma.
   Melanoma Res. 2024 Feb 16. doi: 10.1097/CMR.0000000000000957.
   

   >> Share

   
   
8. DE SMEDT J, Aura C, Van Kelst S, Janssen L, et al
   Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients.
   Melanoma Res. 2024 Feb 13. doi: 10.1097/CMR.0000000000000929.
   

   >> Share

   
   

   
   PLoS One

9. SHIRALKAR J, Anthony T, McCallum GA, Durand DM, et al
   Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
   PLoS One. 2024;19:e0297281.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share